Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome*

Rituximab (RTX), as a B cell-depleting agent, is indicated in treating several malignancies and autoimmune diseases. The management of patients currently receiving RTX and patients starting the medication raised concerns in the pandemic era. Theoretically, suppressing the immune response at the beginning of coronavirus disease 2019 (COVID-19) enhances viral replication, but it prevents acute respiratory distress syndrome as the disease progresses. This review aims to investigate the results of RTX administration in patients during the pandemic era. There is insufficient evidence to definitively conclude on the safety of RTX during the pandemic. For this purpose, high-quality controlled cohort studies, as well as registry-based studies, would be helpful.

Download Full-text

Intravascular large B-cell lymphoma as a cause of terminal acute respiratory distress syndrome: atypical presentation of a rare disease

Aging Clinical and Experimental Research ◽

10.1007/s40520-017-0754-3 ◽

2017 ◽

Vol 30 (1) ◽

pp. 97-99

Author(s):

Ilaria Lazzari ◽

Caterina Galetti ◽

Giulia Corvalli ◽

Roberto Bernardi ◽

Giordano Gianotti ◽

...

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

B Cell ◽

Distress Syndrome ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Atypical Presentation ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Sex-specific association of epidermal growth factor gene polymorphisms with acute respiratory distress syndrome

European Respiratory Journal ◽

10.1183/09031936.00091308 ◽

2008 ◽

Vol 33 (3) ◽

pp. 543-550 ◽

Cited By ~ 16

Author(s):

C. C. Sheu ◽

R. Zhai ◽

L. Su ◽

P. Tejera ◽

M. N. Gong ◽

...

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Respiratory Distress Syndrome ◽

Gene Polymorphisms ◽

Distress Syndrome ◽

Factor Gene ◽

Growth Factor Gene ◽

Epidermal Growth ◽

Specific Association

Download Full-text

Acute Respiratory Distress Syndrome Caused by Influenza B Virus Infection in a Patient with Diffuse Large B-Cell Lymphoma

Case Reports in Medicine ◽

10.1155/2011/647528 ◽

2011 ◽

Vol 2011 ◽

pp. 1-4 ◽

Cited By ~ 3

Author(s):

Silvio A. Ñamendys-Silva ◽

María O. González-Herrera ◽

Julia Texcocano-Becerra ◽

Angel Herrera-Gómez

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Virus Infection ◽

Respiratory Distress Syndrome ◽

Respiratory Distress ◽

B Cell ◽

Critically Ill ◽

Distress Syndrome ◽

Influenza B Virus ◽

Influenza B ◽

B Virus

Influenza B virus infections are less common than infections caused by influenza A virus in critically ill patients, but similar mortality rates have been observed for both influenza types. Pneumonia caused by influenza B virus is uncommon and has been reported in pediatric patients and previously healthy adults. Critically ill patients with pneumonia caused by influenza virus may develop acute respiratory distress syndrome. We describe the clinical course of a critically ill patient with diffuse large B-cell lymphoma nongerminal center B-cell phenotype who developed acute respiratory distress syndrome caused by influenza B virus infection. This paper emphasizes the need to suspect influenza B virus infection in critically ill immunocompromised patients with progressive deterioration of cardiopulmonary function despite treatment with antibiotics. Early initiation of neuraminidase inhibitor and the implementation of guidelines for management of severe sepsis and septic shock should be considered.

Download Full-text